Literature DB >> 12475274

Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa.

Yanjun Zhang1, Gary L Mills, Muraleedharan G Nair.   

Abstract

The bioassay-guided isolation and purification of the hexane extract of the cultured mycelia of Grifola frondosa led to the characterization of a fatty acid fraction and three compounds, ergosterol (1), ergostra-4,6,8(14),22-tetraen-3-one (2), and 1-oleoyl-2-linoleoyl-3-palmitoylglycerol (3). The composition of fatty acid fraction was confirmed as palmitic, oleic, and linoleic acids by GC-MS and by comparison with the retention values of authentic samples. The structures of compounds 1-3 were established by spectroscopic methods. The fatty acid fraction and compounds 1-3 showed cyclooxygenase (COX) enzyme inhibitory and antioxidant activities. The inhibition of COX-1 enzyme by the fatty acid fraction and compounds 1-3 at 250 microg/mL were 98, 37, 55, and 67%, respectively. Similarly, COX-2 enzyme activity was reduced by fatty acid fraction and compounds 1-3 at 250 microg/mL by 99, 37, 70, and 4%, respectively. The inhibitions of liposome peroxidation by the fatty acid fraction and compounds 1 and 2 at 100 microg/mL were 79, 48, and 42%, respectively. This is the first report of compounds 2 and 3 from the cultured mycelia of G. frondosa. The COX inhibitory activities of compounds 1-3 are reported here for the first time.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475274     DOI: 10.1021/jf0257648

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  23 in total

Review 1.  Medicinal mushroom: boon for therapeutic applications.

Authors:  Vivek Kumar Chaturvedi; Sonam Agarwal; Krishna Kumar Gupta; Pramod W Ramteke; M P Singh
Journal:  3 Biotech       Date:  2018-07-23       Impact factor: 2.406

2.  Anti-metastatic effects of ergosterol peroxide from the entomopathogenic fungus Ophiocordyceps gracilioides on 4T1 breast cancer cells.

Authors:  Hiroyuki Morita; Yoshihiro Hayakawa; Min-Kyoung Shin; Fumito Sasaki; Dae-Won Ki; Nwet Nwet Win
Journal:  J Nat Med       Date:  2021-04-27       Impact factor: 2.343

3.  Pharmacological and pharmacokinetic studies with agaricoglycerides, extracted from Grifola frondosa, in animal models of pain and inflammation.

Authors:  Chuncho Han; Bo Cui
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

4.  Both common and specialty mushrooms inhibit adhesion molecule expression and in vitro binding of monocytes to human aortic endothelial cells in a pro-inflammatory environment.

Authors:  Keith R Martin
Journal:  Nutr J       Date:  2010-07-16       Impact factor: 3.271

5.  Medicinal mushrooms: Towards a new horizon.

Authors:  A Ganeshpurkar; G Rai; A P Jain
Journal:  Pharmacogn Rev       Date:  2010-07

6.  The pharmacological potential of mushrooms.

Authors:  Ulrike Lindequist; Timo H J Niedermeyer; Wolf-Dieter Jülich
Journal:  Evid Based Complement Alternat Med       Date:  2005-09       Impact factor: 2.629

Review 7.  Mushrooms: a potential natural source of anti-inflammatory compounds for medical applications.

Authors:  Elsayed A Elsayed; Hesham El Enshasy; Mohammad A M Wadaan; Ramlan Aziz
Journal:  Mediators Inflamm       Date:  2014-11-23       Impact factor: 4.711

Review 8.  NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species.

Authors:  Rajeshwary Ghosh; Azra Alajbegovic; Aldrin V Gomes
Journal:  Oxid Med Cell Longev       Date:  2015-09-20       Impact factor: 6.543

Review 9.  Immunostimulatory properties and antitumor activities of glucans (Review).

Authors:  Luca Vannucci; Jiri Krizan; Petr Sima; Dmitry Stakheev; Fabian Caja; Lenka Rajsiglova; Vratislav Horak; Mustafa Saieh
Journal:  Int J Oncol       Date:  2013-06-05       Impact factor: 5.650

10.  Lignin degradation, ligninolytic enzymes activities and exopolysaccharide production by Grifola frondosa strains cultivated on oak sawdust.

Authors:  Nona A Fernandes; Omoanghe S Isikhuemhen; Elijah I Ohimain
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.